STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7%
Fri, 1 Nov

STRIDES PHARMA SCIENCE has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m7,3266,8587,1514.3%-2.4%
Other incomeRs m7710313026.7%68.0%
TurnoverRs m7,4046,9617,2814.6%-1.7%
ExpensesRs m6,3305,6495,6740.4%-10.4%
Gross profitRs m9221,1432,311102.2%150.6%
DepreciationRs m445429420-2.1%-5.6%
InterestRs m48535340414.4%-16.6%
Profit before taxRs m704631,617249.3%2219.7%
TaxRs m163174136.5%358.4%
Profit after taxRs m544321,543257.4%2778.7%
Gross profit margin%12.616.732.3
Effective tax rate%23.16.74.6
Net profit margin%0.76.221.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.4% on a year-on-year (YoY) basis. The expenses were down by 10.4% YoY during the same period.
  • The company's operating profit increased by 150.6% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 32.3% in 2QFY20 as against 12.6% in 2QFY19.
  • Depreciation charges declined by 5.6% and finance costs declined by 16.6% YoY, respectively.
  • Other income increased by 68.0% YoY during the quarter.
  • Net profit for the quarter increased by 2778.7% YoY. Net profit margins during the quarter increased from 0.7% in 2QFY19 to 21.2% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 4.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.4% QoQ during the same period.
  • The company's operating profit increased by 102.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 32.3% in 2QFY20 as against 16.7% in 1QFY19.
  • Net profit for the quarter increased by 257.4% QoQ, while net profit margins increased from 6.2% in 1QFY19 to 21.2% in 2QFY20.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters,please visit here.

Revealed: How to Get Rich with Just 3 Stocks

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year,STRIDES PHARMA SCIENCE share price has moved down from Rs 424.5 to Rs 390.0, registering a Loss of Rs 34.5 or around 8.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,336.3 (up 0.8%). Over the last one year it has moved down from 14,632.9 to 13,336.3, a gain of 1,297 points (down 8.9%).

Overall, the S&P BSE SENSEX is up 16.7% over the year.

Current Valuations

At the current price of Rs 390.0, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 7.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 0.9 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Elon Musk Gives Us a Trading Opportunity(Fast Profits Daily)

Jul 28, 2020

Elon Musk made a statement recently which I believe, gives us a fast profit trading opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Aug 10, 2020 10:55 AM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - ACTAVIS COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS